Pioneer in kidney cancer radiation and long-term KCP collaborator named new chair of radiation oncology March 21, 2022 Announcement Radiation
Higher doses of cabozantinib may offer hope to kidney cancer patients with few other options March 15, 2022 Patient Story Patient Care, Clinical Trial, Targeted Drugs
CPRIT awards more than $2 million in research funding to UTSW kidney cancer investigators February 22, 2022 Recognition Research, Technology Development, AI-Data Science
Scott Schwartzman, M.D., joins KCP as Co-Leader of Education February 14, 2022 Announcement Education
CenterTimes: Addressing the most feared kidney cancer complication January 7, 2022 Spotlight Patient Care, Radiation, Surgery
Maralice Conacci-Sorrell, Ph.D., named inaugural Co-Leader for Faculty Development December 27, 2021 Announcement Education
SPORE-funded kidney cancer tumorgraft platform to advance precision medicine November 29, 2021 Announcement Immunotherapy, SPORE, Targeted Drugs
CPRIT award brings prominent kidney cancer investigator to UTSW November 1, 2021 Recognition Patient Care, Clinical Trial, Immunotherapy
Novel kidney cancer study sheds light into how cancers invade and metastasize October 12, 2021 Announcement Research, Clinical Trial, Imaging
Study highlights diagnostic advances in classifying oncocytic tumors September 27, 2021 Announcement Discovery, Research
FDA approves first-in-class HIF-2 inhibitor developed at UTSW SPORE August 21, 2021 Announcement Research, HIF2, Targeted Drugs